Published April 2018
| Version v1
Journal article
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience
Creators
- Atalar, Banu1
- Ozsahin, Mahmut2
- Call, Jason3
- Napieralska, Aleksandra4
- Kamer, Serra5
- Villa, Salvador6
- Erpolat, Petek7
- Negretti, Laura2
- Lassen-Ramshad, Yasmin8
- Onal, Cem9
- Akyurek, Serap10
- Ugurluer, Gamze1
- Baumert, Brigitta G.11, 12
- Servagi-Vernat, Stephanie13
- Miller, Robert C.14
- Ozyar, Enis1
- Sio, Terence T.3
- 1. Department of Radiation Oncology, Acıbadem University, Istanbul (Turkey)
- 2. Centre Hospitalier Universitaire Vaudois (CHUV), Department of Radiation Oncology, Lausanne (Switzerland)
- 3. Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ (United States)
- 4. Radiotherapy Department, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch (Poland)
- 5. Department of Radiation Oncology, Ege University, Izmir (Turkey)
- 6. Radiation Oncology, Catalan Institute of Oncology, Badalona, Catalonia (Spain)
- 7. Department of Radiation Oncology, Gazi University, Ankara (Turkey)
- 8. Oncological Department, Aarhus University Hospital (Denmark)
- 9. Department of Radiation Oncology, Baskent University, Adana (Turkey)
- 10. Department of Radiation Oncology, Ankara University, Ankara (Turkey)
- 11. Paracelsus Klinik Osnabrueck and University of Muenster, University Bonn MC (Germany)
- 12. Depts. Radiation Oncology (MAASTRO), GROW, Maastricht University MC (Netherlands)
- 13. Radiation Oncology, University Hospital of Besancon (France)
- 14. Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL (United States)
Description
Background and purposeThe optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We report a large series of cases from the Rare Cancer Network.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2017.12.028Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2017.12.028;
- PII
- S0167814018300136;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 127
- Journal Issue
- 1
- Journal Page Range
- p. 96-102
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 51004962
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; NEOPLASMS; PATIENTS
- Descriptors DEC
- DIAGNOSTIC TECHNIQUES; DISEASES; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.